Ulrike Mock
- Molecular Biology
- Oncology top 5%
- Genetics top 10%
- Immunology
- Biomedical Engineering
- Co-authors
- Boris FehseWaseem QasimDjordje AtanackovicKristoffer RieckenIlona HauberKristoffer WeberUdo BartschRoland Preece
- Topics
- CRISPR and Genetic Engineering (11 papers)CAR-T cell therapy research (11 papers)Virus-based gene therapy research (8 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- BloodOncogeneScientific Reports
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Ulrike Mock
19 papers receiving 841 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 526
- Oncology 463
- Genetics 271
- Immunology 216
- Biomedical Engineering 134
Countries citing papers authored by Ulrike Mock
This map shows the geographic impact of Ulrike Mock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Mock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Mock more than expected).
Fields of papers citing papers by Ulrike Mock
This network shows the impact of papers produced by Ulrike Mock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Mock. The network helps show where Ulrike Mock may publish in the future.
Co-authorship network of co-authors of Ulrike Mock
This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Mock. A scholar is included among the top collaborators of Ulrike Mock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Mock. Ulrike Mock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 82 | |
| 6 | 79 | |
| 7 | 4 | |
| 8 | 100 | |
| 9 | 57 | |
| 10 | 163 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 7 | |
| 15 | 58 | |
| 16 | 127 | |
| 17 | 24 | |
| 18 | 25 | |
| 19 | 22 | |
| 20 | 92 |
About Ulrike Mock
Ulrike Mock is a scholar working on Business and International Management, Oncology and Genetics, having authored 20 papers that have together received 852 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (11 papers), CAR-T cell therapy research (11 papers) and Virus-based gene therapy research (8 papers). The work is most often cited by research in Oncology (463 citations), Immunology (216 citations) and Genetics (271 citations). Ulrike Mock has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Boris Fehse, Waseem Qasim, Djordje Atanackovic, Kristoffer Riecken, Ilona Hauber, Kristoffer Weber, Udo Bartsch, Roland Preece, Ian Johnston and Jane Rasaiyaah. Their work appears in journals such as Blood, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.